Advertisement

Reactions Weekly

, Volume 1710, Issue 1, pp 12–12 | Cite as

Ustekinumab safe but may reactivate hepatitis B

Clinical study
  • 20 Downloads

Reference

  1. Ting SW, et al. Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab. Clinical Drug Investigation : 2 Jul 2018. Available from: URL: http://doi.org/10.1007/s40261-018-0671-z

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations